BlackRock Health Sciences Trust (NYSE:BME) Share Price Passes Below Two Hundred Day Moving Average – Here’s What Happened

BlackRock Health Sciences Trust (NYSE:BME) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $40.33 and traded as low as $39.21. BlackRock Health Sciences Trust shares last traded at $39.3750, with a volume of 36,751 shares changing hands.

BlackRock Health Sciences Trust Trading Down 0.7%

The business has a 50-day simple moving average of $40.35 and a 200 day simple moving average of $40.33.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th will be given a dividend of $0.2621 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 8.0%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its position in shares of BlackRock Health Sciences Trust by 22.2% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after acquiring an additional 257 shares in the last quarter. SOA Wealth Advisors LLC. raised its position in shares of BlackRock Health Sciences Trust by 20.3% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after acquiring an additional 469 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of BlackRock Health Sciences Trust by 200.0% in the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock worth $179,000 after acquiring an additional 3,266 shares in the last quarter. Sage Investment Counsel LLC bought a new position in shares of BlackRock Health Sciences Trust in the 3rd quarter worth approximately $201,000. Finally, Truist Financial Corp bought a new position in shares of BlackRock Health Sciences Trust in the 3rd quarter worth approximately $205,000.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.